Genmab, DK0010272202

Genmab stock last trades at DKK 2,282.00 on September 28, 2026

Published on 09/28/2026 at 20:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Genmab last traded at DKK 2,282.00 on Nasdaq Copenhagen on September 28, 2026, up 0.22 percent. The company also disclosed new employee equity awards.

Fotorealistisches Biotech-Labor mit Forschern in weißen Kitteln bei Antikörperforschung
Genmab A/S entwickelt Antikörpertherapien in modernen Biotech-Laboren mit Forschern und Präzisionsgeräten, Aktie DK0010272202, Illustration mit AI erstellt.

Genmab A/S shares last traded at DKK 2,282.00 on Nasdaq Copenhagen on September 28, 2026, up 0.22 percent from the previous session.

Employee awards disclosed

In a September 24, 2026 company announcement, Genmab said its board had approved grants of 13,794 restricted stock units and 13,331 warrants to employees of Genmab and its subsidiaries. The announcement was issued by Genmab A/S.

Genmab said each restricted stock unit represents a conditional right to receive one Genmab share and had a fair value of DKK 2,268.00 on the grant date. Each warrant was granted at no cost and carries an exercise price of DKK 2,268.00. The restricted stock units and warrants vest after three years, while the warrants expire on the seventh anniversary of the grant date, according to the company announcement.

Disclaimer...

en | DK0010272202 | GENMAB | boerse | 70194584 | bgmi